title: Neonatal hypothyroidism permanently alters follicle-stimulating hormone and luteinizing hormone production in the male rat.
abstract: Transient neonatal hypothyroidism, induced with the goitrogen 6-n-propyl-2-thiouracil (PTU), results in dramatic increases in both testis size and sperm production in the adult rat. The observed increases in testis size and function occur in the presence of normal circulating testosterone levels. However, circulating gonadotropin levels are chronically reduced by 30-50% at all times in treated males. To better understand the permanent reduction in serum gonadotropin levels following transient neonatal hypothyroidism, we conducted a series of experiments to evaluate pituitary and hypothalamic function in the adult male PTU-treated rat. PTU treatment led to a significant reduction in GnRH-stimulated LH production. Castration resulted in 3.9- to 8.5-fold increases in circulating gonadotropin levels in both treated and control males; however, the absolute increases were significantly reduced in treated males. In contrast to circulating levels, pituitary gonadotropin contents did not increase in treated males after castration. PTU treatment did not lead to a reduction in the density of either luteotropes or folliculotropes, and both cell types increased in size and density after castration. The relative concentrations of both gonadotropin beta-subunit messenger RNAs increased more slowly in treated males than in controls after castration. Thus, although treated rats have the intrinsic ability to produce normal circulating levels of LH and FSH, gonadal feedback and an overall reduction in gonadotrope synthetic ability combine to produce the chronically reduced circulating levels of these hormones.
authors.affiliation: Department of Poultry Science, University of Arkansas, Fayetteville 72701, USA. jkirby@comp.uark.edu
authors.forename: J D
authors.initials: JD
authors.lastname: Kirby
authors.forename: N
authors.initials: N
authors.lastname: Arambepola
authors.forename: T
authors.initials: T
authors.lastname: Porkka-Heiskanen
authors.forename: Y K
authors.initials: YK
authors.lastname: Kirby
authors.forename: M L
authors.initials: ML
authors.lastname: Rhoads
authors.forename: H
authors.initials: H
authors.lastname: Nitta
authors.forename: A E
authors.initials: AE
authors.lastname: Jetton
authors.forename: G
authors.initials: G
authors.lastname: Iwamoto
authors.forename: G L
authors.initials: GL
authors.lastname: Jackson
authors.forename: F W
authors.initials: FW
authors.lastname: Turek
authors.forename: P S
authors.initials: PS
authors.lastname: Cooke
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D002369:Castration; D005260:Female; D005640:Follicle Stimulating Hormone / Q000096:biosynthesis* / Q000235:genetics; D007987:Gonadotropin-Releasing Hormone / Q000097:blood; D007037:Hypothyroidism / Q000378:metabolism / Q000503:physiopathology*; D007986:Luteinizing Hormone / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000503:physiopathology*; D011247:Pregnancy; D011441:Propylthiouracil / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013737:Testis / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology
chemical_list: D012333:RNA, Messenger; D007987:Gonadotropin-Releasing Hormone; D011441:Propylthiouracil; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone